Can Biological Markers Lead to a Better Lumpectomy?

Women who are diagnosed with a cancerous tumor in the breasts generally have two options for treatment: a mastectomy, or full removal of the breast(s), or a lumpectomy, a focused removal of the tumor that leaves as much of the breast as possible intact. In my practice, I adopt a conservative approach to breast tissue removal, optimizing the end cosmetic result while maintaining aggressive removal of all cancerous tissue.

The BioZorb™ Surgical Marker

The BioZorb™ surgical marker is an innovative new tissue marker that is surgically implanted into the breast at the location of the tumor. The device itself dissolves into the patient’s body, but leaves behind six eyelash-sized titanium markers that serve as indicators for the exact tumor location.

Why Biological Markers Matter

Normally, after a lumpectomy, the patient must undergo a series of radiation treatments to eliminate any remaining cancer cells. Biological markers are important in the progression of cancer treatment technology because they can allow radiation treatments following a lumpectomy to concentrate more precisely on the tumor itself, with less damage to the surrounding cells and organs.

Potential for Better Cosmetic Results

Focusing radiation exclusively on the tumor as much as possible with the help of biological markers can mean that more natural breast tissue may be saved. When as much healthy breast tissue as possible is conserved, I find that creating optimal breast reconstruction results after a lumpectomy is much more achievable from a surgical standpoint. With a healthy, natural breast appearance, breast cancer patients can move forward from their illness with a sense of wholeness.